Topics

Jazz, Redx Pharma to collaborate on pan-RAF inhibitor program

05:06 EDT 12 Jul 2019 | SmartBrief

Jazz Pharmaceuticals and Redx Pharma have partnered to develop treatments for RAS and RAF mutant tumors through the latter's  -More

Original Article: Jazz, Redx Pharma to collaborate on pan-RAF inhibitor program

NEXT ARTICLE

More From BioPortfolio on "Jazz, Redx Pharma to collaborate on pan-RAF inhibitor program"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...